vancomycin has been researched along with uridine diphosphate n-acetylmuramic acid in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (45.71) | 18.2507 |
2000's | 8 (22.86) | 29.6817 |
2010's | 8 (22.86) | 24.3611 |
2020's | 3 (8.57) | 2.80 |
Authors | Studies |
---|---|
Allen, NE; Hobbs, JN; Richardson, JM; Riggin, RM | 1 |
Billot-Klein, D; Collatz, E; Gutmann, L; van Heijenoort, J | 1 |
Arthur, M; Courvalin, P; Molinas, C; Walsh, CT; Wright, GD | 1 |
Messer, J; Reynolds, PE | 1 |
Handwerger, S; Lee, MS; Liu, J; Pucci, MJ; Volk, KJ | 2 |
Höltje, JV; Kohlrausch, U | 1 |
Allen, NE; Hobbs, JN | 1 |
Billot-Klein, D; Buu-Hoi, A; Gutmann, L; Pierre, J; Rosato, A | 1 |
Handwerger, S | 1 |
Allen, NE; Bernard, N; Delcour, J; Ferain, T; Garmyn, D; Hobbs, JN; Hols, P; Richardson, J | 1 |
Allen, NE; Hobbs, JN; Nicas, TI | 1 |
Allen, NE; Hobbs, JN; LeTourneau, DL | 1 |
Gutmann, L; Sifaoui, F | 1 |
Bierbaum, G; Brötz, H; Reynolds, PE; Sahl, HG | 1 |
Bell, D; Billot-Klein, D; Bryant, D; Gutmann, L; Legrand, R; Shlaes, D; van Heijenoort, J | 1 |
Breukink, E; Heck, AJ; Vollmerhaus, PJ | 1 |
Barrett, D; Chen, L; Donadio, S; Falcone, B; Kahne, D; Leimkuhler, C; Oberthür, M; Panzone, G; Sun, B; Walker, S | 1 |
Ayala, JA; Lara, B; Mengin-Lecreulx, D; van Heijenoort, J | 1 |
Breukink, E; de Kruijff, B; Hasper, HE; Hillman, JD; Kramer, NE; Kuipers, OP; Smith, JL; Zachariah, C | 1 |
Breukink, E; Martin, NI | 1 |
Arnusch, CJ; Bonvin, AM; Breukink, E; de Kruijff, B; Jansen, WT; Liskamp, RM; Pieters, RJ; Verel, AM | 1 |
Benton, BM; Hartouni, SR; Humphrey, PP; Janc, JW; Lunde, CS; Mammen, M | 1 |
Arnusch, CJ; Bauke Albada, H; Branderhorst, HM; Breukink, E; de Kruijff, B; Janssen, WT; Liskamp, RM; Pieters, RJ; Verel, AM | 1 |
Sahl, HG; Schneider, T | 1 |
Andersen, AS; Bonvin, AM; De Maria, L; Gammelgaard, LK; Jansen, A; Kristensen, HH; Kruse, T; Mygind, PH; Neve, S; Nielsen, AK; Pag, U; Raventós, DS; Ravn, B; Sahl, HG; Sass, V; Schneider, T; Wiedemann, I; Wimmer, R | 1 |
Al-Kaddah, S; Bendas, G; Brunschweiger, M; Klocek, G; Reder-Christ, K; Wiedemann, I | 1 |
Blanke, SR; Gut, IM; van der Donk, WA | 1 |
Cooper, MA; Jia, Z; Mark, AE; O'Mara, ML; Zuegg, J | 1 |
Catel-Ferreira, M; Chapot-Chartier, MP; Courtin, P; El Meouche, I; Lemée, L; Peltier, J; Pons, JL | 1 |
Chang, JD; Foster, EE; Kim, SJ; Yang, H | 1 |
Grein, F; Sahl, HG; Schneider, T | 1 |
Boes, A; Breukink, E; Mohammadi, T; Olatunji, S; Terrak, M | 1 |
Liang, Y; Wang, Q; Yan, X; Yang, L; Zhao, W | 1 |
Cebrián, R; Kuipers, OP; Li, Q; Montalbán-López, M; Ren, H; Wu, W | 1 |
3 review(s) available for vancomycin and uridine diphosphate n-acetylmuramic acid
Article | Year |
---|---|
Expanding role of lipid II as a target for lantibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteriocins; Drug Resistance, Bacterial; Models, Molecular; Molecular Sequence Data; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2007 |
Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Topics: Anti-Bacterial Agents; Cell Wall; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Terpenes; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2010 |
Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriocins; Biological Products; Biosynthetic Pathways; Cell Wall; Defensins; Depsipeptides; Drug Resistance, Bacterial; Glycopeptides; Molecular Docking Simulation; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2019 |
32 other study(ies) available for vancomycin and uridine diphosphate n-acetylmuramic acid
Article | Year |
---|---|
Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium.
Topics: Amino Acid Sequence; Drug Resistance, Microbial; Enterococcus faecium; Molecular Sequence Data; Peptidoglycan; Protein Precursors; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1992 |
Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.
Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Dipeptides; Drug Resistance, Microbial; Enterococcus; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1992 |
Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147.
Topics: Carboxypeptidases; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Enterococcus faecium; Multigene Family; R Factors; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1992 |
Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.
Topics: Amino Acid Sequence; Cell Wall; Cytoplasm; Drug Resistance, Microbial; Enterococcus faecium; Glycopeptides; Hexosamines; Mass Spectrometry; Molecular Sequence Data; Peptidoglycan; Protein Precursors; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1992 |
The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
Topics: Amino Acid Sequence; Cytoplasm; Drug Resistance, Microbial; Enterococcus faecalis; Mass Spectrometry; Molecular Sequence Data; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1992 |
One-step purification procedure for UDP-N-acetylmuramyl-peptide murein precursors from Bacillus cereus.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Bacillus cereus; Chromatography, High Pressure Liquid; Peptidoglycan; Protein Precursors; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1991 |
Induction of vancomycin resistance in Enterococcus faecium by non-glycopeptide antibiotics.
Topics: Anti-Bacterial Agents; Antimetabolites; Bacitracin; Cycloserine; Drug Resistance, Microbial; Enterococcus faecium; Lactates; Lactic Acid; Penicillin G; Penicillins; Peptidoglycan; Signal Transduction; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1995 |
Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.
Topics: Adult; Base Sequence; Drug Resistance, Microbial; Enterococcus; Female; Glycopeptides; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1995 |
Alterations in peptidoglycan precursors and vancomycin susceptibility in Tn917 insertion mutants of Enterococcus faecalis 221.
Topics: Amino Acid Sequence; Carboxypeptidases; Cytoplasm; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Oligopeptides; Peptidoglycan; Plasmids; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1994 |
Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate.
Topics: Amino Acid Sequence; Drug Resistance, Microbial; Lactates; Lacticaseibacillus casei; Leuconostoc; Molecular Sequence Data; Peptidoglycan; Protein Precursors; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1994 |
Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Genes, Bacterial; Glycopeptides; L-Lactate Dehydrogenase; Lactic Acid; Lactobacillus; Mass Spectrometry; Mutagenesis; Peptidoglycan; Teicoplanin; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1996 |
Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Lipid Metabolism; Penicillin Resistance; Penicillins; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1996 |
Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
Topics: Anti-Bacterial Agents; Binding, Competitive; Carboxypeptidases; Drug Resistance, Microbial; Peptidoglycan; Protein Binding; Streptococcaceae; Substrate Specificity; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1997 |
Vancomycin dependence in a vanA-producing Enterococcus avium strain with a nonsense mutation in the natural D-Ala-D-Ala ligase gene.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus; Genes, Bacterial; Molecular Sequence Data; Mutation; Operon; Peptide Synthases; Sequence Homology, Amino Acid; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1997 |
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus megaterium; Bacterial Proteins; Bacteriocins; Cell Wall; Chromatography, High Pressure Liquid; Enterococcus; Glycosylation; Membrane Lipids; Molecular Sequence Data; Muramic Acids; Mutation; Peptides; Peptidoglycan; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1997 |
Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Peptides, Cyclic; Staphylococcus; Staphylococcus aureus; Tunicamycin; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1997 |
Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics.
Topics: Anti-Bacterial Agents; Cell Wall; Lipid Metabolism; Lipids; Microbial Sensitivity Tests; Micrococcus; Molecular Mimicry; Protein Binding; Ristocetin; Solubility; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Water | 2003 |
Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Topics: Anti-Bacterial Agents; Dipeptides; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcus aureus; Substrate Specificity; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2005 |
Peptidoglycan precursor pools associated with MraY and FtsW deficiencies or antibiotic treatments.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbohydrate Sequence; Cephaloridine; Chromatography, High Pressure Liquid; Escherichia coli; Membrane Proteins; Molecular Sequence Data; Oligosaccharides; Penicillin G; Peptidoglycan; Protein Precursors; Transferases; Transferases (Other Substituted Phosphate Groups); Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2005 |
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Topics: Anti-Bacterial Agents; Bacillus; Bacillus megaterium; Bacillus subtilis; Bacteriocins; Cell Division; Cell Wall; Lipid Bilayers; Membranes, Artificial; Nisin; Peptides; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2006 |
The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.
Topics: Anti-Bacterial Agents; Drug Combinations; Enterococcus; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Nisin; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Vancomycin Resistance | 2008 |
Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Wall; Flow Cytometry; Lipoglycopeptides; Membrane Potentials; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Staphylococcus aureus; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2009 |
Potential scorpionate antibiotics: targeted hydrolysis of lipid II containing model membranes by vancomycin-TACzyme conjugates and modulation of their antibacterial activity by Zn-ions.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Catalysis; Cell Membrane; Dendrimers; Hydrolysis; Imidazoles; Microbial Sensitivity Tests; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Zinc Sulfate | 2009 |
Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Topics: Anti-Bacterial Agents; Ascomycota; Bacillus subtilis; Binding Sites; Cell Membrane; Cell Wall; Computer Simulation; Defensins; Fungal Proteins; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Oligonucleotide Array Sequence Analysis; Peptides; Protein Conformation; Staphylococcus; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2010 |
Analysis of membrane interactions of antibiotic peptides using ITC and biosensor measurements.
Topics: Antimicrobial Cationic Peptides; Bacteriocins; Biosensing Techniques; Calorimetry; Kinetics; Liposomes; Peptides; Phosphatidylcholines; Protein Binding; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2010 |
Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
Topics: Anti-Bacterial Agents; Bacillus anthracis; Boron Compounds; Cell Membrane; Cell Wall; Fluorescent Dyes; Membrane Potentials; Mutation; Nisin; Spores, Bacterial; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2011 |
The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II.
Topics: Amino Acid Sequence; Crystallography, X-Ray; Dimerization; Entropy; Membranes, Artificial; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Structure-Activity Relationship; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2011 |
Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Multigene Family; Operon; Phylogeny; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Vancomycin Resistance | 2013 |
Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
Topics: Alanine; Anti-Bacterial Agents; Cell Wall; Dipeptides; Endopeptidases; Enterococcus faecalis; Lactates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Vancomycin Resistance | 2017 |
Fluorescence anisotropy assays for high throughput screening of compounds binding to lipid II, PBP1b, FtsW and MurJ.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Depsipeptides; Escherichia coli Proteins; Fluorescence Polarization; High-Throughput Screening Assays; Membrane Proteins; Nisin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Phospholipid Transfer Proteins; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2020 |
A Biochemical Lanthanide-Encoding Approach Enables Quantitative Monitoring of the Bacterial Response to Vancomycin Treatment.
Topics: Alanine; Anti-Bacterial Agents; Europium; Gadolinium; Isotope Labeling; Lanthanoid Series Elements; Leucine; Methionine; Microbial Viability; Peptidoglycan; Samarium; Staphylococcus aureus; Stereoisomerism; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2020 |
Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Nisin; Peptides; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2021 |